Jeff Mann serves as Senior Vice President, General Counsel and Product Development, prior to which he served as the Senior Vice President, General Counsel and Head of Corporate Development of Diabetes Care at BD until the Separation. Previously, Jeff served as General Counsel and Corporate Secretary of Cantel Medical Corp (Cantel).
Prior to Cantel, Jeff spent 14 years with Boston Scientific Corporation in roles including M&A, venture capital investments, SEC and corporate governance, patent strategy, litigation, and business unit support for the Med Surg group. Jeff also served on the Board of Directors of Preventice Solutions and as Chair of its Compensation Committee. He holds a Bachelor of Science degree in Civil and Environmental Engineering from Lafayette College and a J.D. from Boston College Law School, magna cum laude.
Mr. Mann became Senior Vice President, General Counsel, Head of Corporate Development and Corporate Secretary of Embecta as of the Effective Time of the spin-off from BD on April 1, 2022.